Sale!

RBM20 Gene Cardiomyopathy Dilated Type 1DD Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The RBM20 Gene Cardiomyopathy Dilated Type 1DD Genetic Test is a specialized diagnostic assessment designed to detect mutations in the RBM20 gene, which are associated with Dilated Cardiomyopathy (DCM) Type 1DD. This condition is a form of heart disease characterized by the enlargement and weakening of the heart’s main pumping chamber, leading to decreased heart function and, potentially, heart failure. The test plays a crucial role in early detection, allowing for timely intervention and management of the condition.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific genetic mutations in the RBM20 gene known to contribute to the development of Dilated Cardiomyopathy.

The cost of the RBM20 Gene Cardiomyopathy Dilated Type 1DD Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, covering the cost of sample collection, genetic analysis, and the provision of a detailed report by the laboratory’s genetic specialists. The report not only confirms the presence or absence of the RBM20 mutation but also provides insights into the patient’s risk of developing the condition and guidance for clinical management.

Given the genetic basis of Type 1DD Dilated Cardiomyopathy, this test is particularly valuable for individuals with a family history of the condition, offering them an opportunity for early detection and the adoption of preventive health measures.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

RBM20 Gene Cardiomyopathy dilated type 1DD Genetic Test

Test Name: RBM20 Gene Cardiomyopathy dilated type 1DD Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for RBM20 Gene Cardiomyopathy, dilated type 1DD NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RBM20 Gene Cardiomyopathy, dilated type 1DD NGS Genetic DNA Test gene RBM20

Test Details: RBM20 gene cardiomyopathy, dilated type 1DD is a specific type of genetic disorder that affects the heart muscle. It is caused by mutations in the RBM20 gene, which provides instructions for making a protein involved in the regulation of cardiac muscle function. Individuals with RBM20 gene cardiomyopathy, dilated type 1DD may develop dilated cardiomyopathy, which is characterized by the enlargement and weakening of the heart muscle. This can lead to symptoms such as fatigue, shortness of breath, chest pain, and heart palpitations. In severe cases, it can result in heart failure or sudden cardiac death.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA to identify genetic mutations or variations. In the case of RBM20 gene cardiomyopathy, dilated type 1DD, NGS genetic testing can detect mutations in the RBM20 gene to confirm the diagnosis. This type of genetic testing is typically performed using a blood sample or a saliva sample. The DNA is extracted from the sample and then sequenced using NGS technology. The resulting sequence data is then analyzed to identify any mutations or variations in the RBM20 gene.

NGS genetic testing for RBM20 gene cardiomyopathy, dilated type 1DD can help with the diagnosis of the condition, as well as provide information about the risk of developing symptoms or passing on the condition to future generations. It can also be used to guide treatment decisions and inform genetic counseling for affected individuals and their families.

Test Name RBM20 Gene Cardiomyopathy dilated type 1DD Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for RBM20 Gene Cardiomyopathy, dilated type 1DD NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RBM20 Gene Cardiomyopathy, dilated type 1DD NGS Genetic DNA Test gene RBM20
Test Details

RBM20 gene cardiomyopathy, dilated type 1DD is a specific type of genetic disorder that affects the heart muscle. It is caused by mutations in the RBM20 gene, which provides instructions for making a protein involved in the regulation of cardiac muscle function.

Individuals with RBM20 gene cardiomyopathy, dilated type 1DD may develop dilated cardiomyopathy, which is characterized by the enlargement and weakening of the heart muscle. This can lead to symptoms such as fatigue, shortness of breath, chest pain, and heart palpitations. In severe cases, it can result in heart failure or sudden cardiac death.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA to identify genetic mutations or variations. In the case of RBM20 gene cardiomyopathy, dilated type 1DD, NGS genetic testing can detect mutations in the RBM20 gene to confirm the diagnosis.

This type of genetic testing is typically performed using a blood sample or a saliva sample. The DNA is extracted from the sample and then sequenced using NGS technology. The resulting sequence data is then analyzed to identify any mutations or variations in the RBM20 gene.

NGS genetic testing for RBM20 gene cardiomyopathy, dilated type 1DD can help with the diagnosis of the condition, as well as provide information about the risk of developing symptoms or passing on the condition to future generations. It can also be used to guide treatment decisions and inform genetic counseling for affected individuals and their families.